Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rank in Stocks #7326
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Share Price
$36.75
Last synced: 2026-08-27
Market Cap
$1.63B
Change (1 day)
-0.78%
Change (1 year)
-
Country
US
Trade Avalyn Pharma Inc. Common Stock (AVLN)

Category

Stock price history for Avalyn Pharma Inc. Common Stock (AVLN)
Highest end of day price: $36.94 on 2026-08-01

Lowest end of day price: $29.49 on 2026-04-01
Stock price history of Avalyn Pharma Inc. Common Stock from 2026 to 2026
Annual Stock Price Performance
Year Performance
Not enough data for the provided dates.
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$766.55 7.92%
CH